P
PTG
vs
W
WIG20
Over the past 12 months, PTG has underperformed WIG20, delivering a return of -33% compared to the WIG20's +31% growth.
Stocks Performance
PTG vs WIG20
Performance Gap
PTG vs WIG20
Performance By Year
PTG vs WIG20
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Poltreg SA
Glance View
PolTREG SA develops and commercializes patented TREG methods. The company is headquartered in Gdansk, Woj. Pomorskie and currently employs 11 full-time employees. The company went IPO on 2021-11-23. The firm conducts research in the field of autoimmunological diseases. The firm works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The firm works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The firm is developing its own research center, which is intended as a basic location for conducting future research activities.
